Skip to main content
  • Donate
  • News
  • Events
  • Contact us
UNSW logo
  • Kirby Institute
  • Research Research
      Kirby Institute
      Research
    • Focus areas Focus areas
        Research
        Focus areas
      • First Nations health
      • COVID-19 and emerging infections
      • Global health
      • HIV
      • Human papillomavirus (HPV)
      • Sexual health
      • Viral hepatitis
    • Research strengths Research strengths
        Research
        Research strengths
      • Biostatistics, modelling and analysis
      • Capacity building
      • Clinical trials and cohorts
      • Epidemiology and surveillance
      • Health economics and health systems
      • Immunovirology
      • New diagnostic approaches
      • Public health interventions
      • Social and behavioural sciences
    • Research teams Research teams
        Research
        Research teams
      • Research programs
      • Research groups
      • Advisory committees
    • Projects & reports Projects & reports
        Research
        Projects & reports
      • Projects
      • Reports
  • Study Study
      Kirby Institute
      Study
    • Future students Future students
        Study
        Future students
      • Postgraduate research
      • David Cooper Scholarship
      • Research opportunities
    • Research training Research training
        Study
        Research training
      • Cooper HIV/AIDS Research Training (CHART) Program
  • Support Support
      Kirby Institute
      Support
    • Support our research Support our research
        Support
        Support our research
      • Donate
      • David Cooper Memorial Fund
      • Gifts in will
    • Get involved Get involved
        Support
        Get involved
      • Join the community
  • About About
      Kirby Institute
      About
    • Who we are Who we are
        About
        Who we are
      • About us
      • Our people
      • Annual reports
      • Inaugural director
      • History
      • Contact us
    • Our structure Our structure
        About
        Our structure
      • Director
      • Leadership
      • Organisational structure
      • Research programs
      • Operations
    • News & events News & events
        About
        News & events
      • News
      • Events
      • Kirby Institute Newsletter

Breadcrumb

  1. Kirby Institute
  2. Reports
  3. Monitoring hepatitis C treatment uptake in Australia Issue 12, July 2022

Follow

Follow
Hepatitis C illustration as blue cells. Credit: Shutterstock

Monitoring hepatitis C treatment uptake in Australia Issue 12, July 2022

This report summarises data on the prescription and distribution of hepatitis C treatments and provides insight into the initial phase of the roll-out of direct-acting antiviral therapy in Australia. 

Monitoring hepatitis C treatment uptake in Australia Issue 12, July 2022 433.43 KB pdf
Report contact
Associate Professor

Behzad Hajarizadeh

View Profile
Year published
2022
Report type
Research reports
Research program
Viral Hepatitis Clinical Research Program
Focus areas
Viral hepatitis
Research strengths
Biostatistics, modelling and analysis
Epidemiology and surveillance
Latest news
  • Left or right arm? New research reveals why vaccination site matters for immune response
  • New $1.9M grant will help improve models of care for people living with HIV
  • Point-of-Care: the infectious disease-testing revolution
  • Research grant of $796k will help boost anal cancer prevention services
  • Dr Sarah Sasson appointed head of Immunovirology and Pathogenesis Program

Support our work

Your generous support will make a huge impact.

Donate today

Stay informed

Subscribe to Kin, our quarterly newsletter.

Subscribe now

Want to know more?

If you have any questions, let us know.

Contact us